Sanofi S.A.- ADR operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A.- ADR with three other
companies in this sector in the United States:
Bayer AG
(2018
sales of $46.64 billion
of which 42%
was Pharmaceuticals & Biological Products),
Merck & Co. , Inc.
($42.29 billion
of which 89%
was Merck Pharmaceutical), and
GlaxoSmithKline plc
($41.01 billion
of which 56%
was Pharmaceuticals).
Sales Analysis.
During the year ended December of 2018, sales at
Sanofi S.A.- ADR were $42.04 billion.
This
is
a very small
increase of 1.9%
versus 2017, when the company's sales were $41.24 billion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Sanofi S.A.- ADR had sales
of $44.30 billion.
Sales of Vaccines saw an increase
of
3.8% in 2018, from
$5.81 billion to $6.03 billion.
Not all segments of Sanofi S.A.- ADR experienced an increase in sales in 2018:
sales of Pharmaceuticals fell 14.8% to $29.09 billion.